Proud to share important global regulatory updates for our lead disease-agnostic optogenetic therapy, MCO-010: Read the full PR: bit.ly/3Vs3NIv #retina #ophthalmology #Retinitispigmentosa #stargardt
Nanoscope Therapeutics
@NSTherapeutics
Developing a new generation of Optogenetic Therapy designed to restore vision lost to inherited retinal disease
560 Following 1.4K Followers 234 Posts
Latest posts 5
Excited to attend #ASRS2025 in Long Beach! See you there. @asrsdocs
tp://bit.ly/3TX3dSx
#retinitispigmentosa #ophthalmology #retina #rp @NSTherapeutics
tp://bit.ly/3TX3dSx
#retinitispigmentosa #ophthalmology #retina #rp @NSTherapeutics
A new peer-reviewed paper has been published highlighting groundbreaking research that supports our lead asset therapy, MCO-010, and its potential to help restore vision in people living with retinal degenerative diseases. bit.ly/3IH0DgX #RP #fightblindness
We are proud to announce the initiation of a rolling submission of a BLA to the US FDA for our lead investigational therapy, MCO-010, for the treatment of severe vision loss due to #retinitispigmentosa #RP bit.ly/4nO7PYD #fightblindness
